SCHEMBL7423409

SCHEMBL7423409

Cc1cnc(CC=C2C(=O)Nc3ccccc32)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ GAA P10253 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ GSK3B P49841 3/20 0.47
▸ POLB P06746 2/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ EGFR P00533 1/20 0.45
▸ ALDH1A1 P00352 4/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ TGM2 P21980 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ IDO1 P14902 1/20 0.44
▸ ALK Q9UM73 1/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001044 0.78 MAPT (0.59) MAPTKMT2ANPC1GAATDP1
SCHEMBL6001045 0.78 MAPT (0.59) MAPTKMT2ANPC1GAATDP1
SCHEMBL1444136 0.72 MAPT (0.54) MAPTNPC1SMN1; SMN2ALDH1A1NPSR1
SCHEMBL1444503 0.72 MAPT (0.54) MAPTNPC1SMN1; SMN2ALDH1A1NPSR1
SCHEMBL7421627 0.72 KDR (0.48) MAPTKMT2ANPC1TDP1SMN1; SMN2
SCHEMBL7534633 0.70 GSK3B (0.47) MAPTKMT2AGSK3BPOLBSMN1; SMN2
SCHEMBL7416167 0.70 ALDH1A1 (0.61) MAPTKMT2ANPC1TDP1GSK3B
SCHEMBL7421881 0.70 EGFR (0.51) MAPTKMT2ANPC1TDP1POLB
SCHEMBL7422702 0.69 GSK3B (0.49) MAPTKMT2ANPC1GAATDP1
SCHEMBL7421021 0.69 GSK3B (0.46) MAPTKMT2ANPC1GAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0769947-A4 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE SUGEN INC (US) 1998-09-30 — — EP disclosed
EP-0769947-A1 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE Sugen, Inc. (US) 1997-05-02 — — EP disclosed
WO-1996040116-A1 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE SUGEN, INC. (US) 1996-12-19 — — WO disclosed
Send feedback